Learn More
Apexbio Technology LLC ODN 1826 sodium 1mg

Supplier: Apexbio Technology LLC A89811
ODN 1826 sodium is a synthetic oligodeoxynucleotide agonist targeting Toll-like receptor 9 (TLR9) It is designed to activate TLR9-mediated immune responses thereby modulating both innate and adaptive immunity ODN 1826 sodium exerts its biological activity primarily through direct interaction with TLR9 which is expressed in intracellular compartments of immune cells such as dendritic cells macrophages and B lymphocytes Upon binding it triggers downstream signaling cascades leading to the secretion of cytokines including type I interferons and interleukin-12 (IL-12) promoting the polarization of T-helper type 1 (Th1) immune responses Based on these pharmacological properties ODN 1826 sodium holds research potential in studies of immune activation mechanisms tumor immunology infectious disease modeling and vaccine adjuvant development
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.